Free Trial
The Rate Lock Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 a Year
Claim MarketBeat All Access Sale Promotion

Humana (HUM) Expected to Announce Earnings on Friday

Humana logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Humana is expected to report Q3 2026 earnings before the market opens on Friday, November 6. Analysts forecast a loss of $1.00 per share on revenue of approximately $40.87 billion.
  • In its latest quarter, Humana exceeded expectations with $7.61 in EPS and $40.89 billion in revenue, while revenue increased 26.2% year over year.
  • Analysts maintain a consensus “Moderate Buy” rating with an average price target of $453.30. Humana also declared a quarterly dividend of $0.885 per share, representing a 0.9% yield.
  • Five stocks we like better than Humana.

Humana (NYSE:HUM - Get Free Report) is expected to be posting its Q3 2026 results before the market opens on Friday, November 6th. Analysts expect the company to post earnings of ($1.00) per share and revenue of $40.87 billion for the quarter. Investors can find conference call details on the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Friday, November 6, 2026 at 8:00 AM ET.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. During the same period in the previous year, the firm earned $6.27 EPS. The business's revenue for the quarter was up 26.2% on a year-over-year basis. On average, analysts expect Humana to post $9.03 EPS for the current fiscal year and $16.02 EPS for the next fiscal year.

Humana Stock Up 0.9%

HUM stock opened at $415.55 on Friday. The firm has a market cap of $49.90 billion, a PE ratio of 39.31, a P/E/G ratio of 2.54 and a beta of 0.74. Humana has a 12 month low of $163.11 and a 12 month high of $456.50. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a 50 day simple moving average of $400.25 and a 200 day simple moving average of $308.01.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be issued a $0.8850 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana's dividend payout ratio is currently 33.49%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. TD Cowen increased their price objective on Humana from $350.00 to $370.00 and gave the company a "hold" rating in a research report on Friday, July 31st. Zacks Research lowered Humana from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 11th. Wells Fargo & Company upgraded Humana from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $227.00 to $502.00 in a report on Monday, July 13th. Raymond James Financial upgraded Humana from a "market perform" rating to an "outperform" rating and set a $520.00 target price on the stock in a report on Monday, October 12th. Finally, Mizuho boosted their target price on Humana from $468.00 to $495.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 13th. Twenty-one investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $453.30.

Get Our Latest Stock Report on HUM

Humana Company Profile

(Get Free Report)

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company's primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.

See Also

Earnings History for Humana (NYSE:HUM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Humana Right Now?

Before you consider Humana, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.

While Humana currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines